Pulmonary Rehabilitation and Pharmacotherapy

Robert G Varadi; Roger Goldstein

doi:10.1055/s-0029-1242633

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2009; 30(6): 636-648
DOI: 10.1055/s-0029-1242633

Pulmonary Rehabilitation and Pharmacotherapy

Robert G. Varadi¹ , Roger Goldstein¹ ^, ²

¹Division of Respiratory Medicine, West Park Healthcare Centre, Toronto, Ontario, Canada
²Department of Medicine and Physical Therapy, University of Toronto, Toronto, Ontario, Canada

Abstract

ABSTRACT

Though pulmonary rehabilitation can have potent effects on exercise capacity and quality of life in chronic obstructive pulmonary disease (COPD), not all patients benefit to the same degree. Enabling patients to achieve higher training intensities may improve exercise capacity. Adding pharmacological agents to target the abnormal ventilatory mechanics or skeletal muscle dysfunction may enhance the effects of exercise training. This review discusses the rationale and clinical evidence supporting the use of pharmacological adjuncts during the course of pulmonary rehabilitation.

KEYWORDS

COPD - exercise training - bronchodilators - oxygen - helium - anabolic agents

Full Text

References

REFERENCES

1 Ries A L, Bauldoff G S, Carlin B W et al.. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007; 131(5, Suppl) 4S-42S
2 Lacasse Y, Goldstein R, Lasserson T J, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006; (4) CD003793
3 Nici L, Donner C, Wouters E ATS/ERS Pulmonary Rehabilitation Writing Committee et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006; 173 1390-1413
4 Griffiths T L, Burr M L, Campbell I A et al.. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000; 355 362-368
5 Ries A L, Kaplan R M, Myers R, Prewitt L M. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med. 2003; 167 880-888
6 Gimenez M, Servera E, Vergara P, Bach J R, Polu J M. Endurance training in patients with chronic obstructive pulmonary disease: a comparison of high versus moderate intensity. Arch Phys Med Rehabil. 2000; 81 102-109
7 Puente-Maestu L, Sánz M L, Sánz P, Ruíz de Oña J M, Rodríguez-Hermosa J L, Whipp B J. Effects of two types of training on pulmonary and cardiac responses to moderate exercise in patients with COPD. Eur Respir J. 2000; 15 1026-1032
8 Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner C F, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis. 1991; 143 9-18
9 Maltais F, LeBlanc P, Jobin J et al.. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997; 155 555-561
10 Ofir D, Laveneziana P, Webb K A, Lam Y M, O’Donnell D E. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 177 622-629
11 O’Donnell D E, Revill S M, Webb K A. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 164 770-777
12 O’Donnell D E, Webb K A. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis. 1993; 148 1351-1357
13 O’Donnell D E, Aaron S, Bourbeau J Canadian Thoracic Society et al. State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J. 2004; 11(Suppl B) 7B-59B
14 Berry M J, Rejeski W J, Adair N E, Ettinger Jr W H, Zaccaro D J, Sevick M A. A randomized, controlled trial comparing long-term and short-term exercise in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2003; 23 60-68
15 Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med. 2000; 109 207-212
16 Wedzicha J A, Bestall J C, Garrod R, Garnham R, Paul E A, Jones P W. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J. 1998; 12 363-369
17 O’Donnell D E, Hernandez P, Kaplan A et al.. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2008 update—highlights for primary care. Can Respir J. 2008; 15(Suppl A) 1A-8A
18 Celli B R, MacNee W. ATS/ERS Task Force . Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004; 23 932-946
19 Tashkin D P, Celli B, Senn S UPLIFT Study Investigators et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008; 359 1543-1554
20 Barr R G, Bourbeau J, Camargo C A, Ram F S. Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005; (2) CD002876
21 Calverley P M, Anderson J A, Celli B TORCH investigators et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007; 356 775-789
22 Sin D D, McAlister F A, Man S F, Anthonisen N R. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA. 2003; 290 2301-2312
23 Sridhar M, Taylor R, Dawson S, Roberts N J, Partridge M R. A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease. Thorax. 2008; 63 194-200
24 Maltais F, Bourbeau J, Shapiro S Chronic Obstructive Pulmonary Disease Axis of Respiratory Health Network, Fonds de recherche en santé du Québec et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2008; 149 869-878
25 O’Donnell D E, Voduc N, Fitzpatrick M, Webb K A. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J. 2004; 24 86-94
26 Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest. 2003; 124 1743-1748
27 Casaburi R, Mahler D A, Jones P W et al.. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002; 19 217-224
28 O’Donnell D E, Flüge T, Gerken F et al.. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004; 23 832-840
29 Man W D, Mustfa N, Nikoletou D et al.. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax. 2004; 59 471-476
30 Liesker J J, Van De Velde V, Meysman M et al.. Effects of formoterol (Oxis Turbuhaler) and ipratropium on exercise capacity in patients with COPD. Respir Med. 2002; 96 559-566
31 Grove A, Lipworth B J, Reid P et al.. Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease. Thorax. 1996; 51 689-693
32 Casaburi R, Kukafka D, Cooper C B, Witek Jr T J, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005; 127 809-817
33 Lindsay M, Lee A, Chan K et al.. Does pulmonary rehabilitation give additional benefit over tiotropium therapy in primary care management of chronic obstructive pulmonary disease? Randomized controlled clinical trial in Hong Kong Chinese. J Clin Pharm Ther. 2005; 30 567-573
34 Weiner P, Magadle R, Berar-Yanay N, Davidovich A, Weiner M. The cumulative effect of long-acting bronchodilators, exercise, and inspiratory muscle training on the perception of dyspnea in patients with advanced COPD. Chest. 2000; 118 672-678
35 Nocturnal Oxygen Therapy Trial Group . Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980; 93 391-398
36 Report of the Medical Research Council Working Party . Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet. 1981; 1 681-686
37 Bradley J M, Lasserson T, Elborn S, Macmahon J, O’Neill B. A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest. 2007; 131 278-285
38 Somfay A, Pórszász J, Lee S M, Casaburi R. Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPD patients. Chest. 2002; 121 393-400
39 Somfay A, Porszasz J, Lee S M, Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J. 2001; 18 77-84
40 O’Donnell D E, D’Arsigny C, Webb K A. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 163 892-898
41 O’Donnell D E, Bain D J, Webb K A. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med. 1997; 155 530-535
42 Libby D M, Briscoe W A, King T K. Relief of hypoxia-related bronchoconstriction by breathing 30 per cent oxygen. Am Rev Respir Dis. 1981; 123 171-175
43 Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med. 2003; 168 1034-1042
44 Wadell K, Henriksson-Larsén K, Lundgren R. Physical training with and without oxygen in patients with chronic obstructive pulmonary disease and exercise-induced hypoxaemia. J Rehabil Med. 2001; 33 200-205
45 Rooyackers J M, Dekhuijzen P N, Van Herwaarden C L, Folgering H T. Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise. Eur Respir J. 1997; 10 1278-1284
46 Garrod R, Paul E A, Wedzicha J A. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax. 2000; 55 539-543
47 Fichter J, Fleckenstein J, Stahl C, Sybrecht G W. Effect of oxygen (FI02: 0.35) on the aerobic capacity in patients with COPD [in German]. Pneumologie. 1999; 53 121-126
48 Nonoyama M L, Brooks D, Lacasse Y, Guyatt G H, Goldstein R S. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007; (2) CD005372
49 Lacasse Y, Lecours R, Pelletier C, Bégin R, Maltais F. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J. 2005; 25 1032-1038
50 Nonoyama M L, Brooks D, Guyatt G H, Goldstein R S. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med. 2007; 176 343-349
51 Eaton T, Garrett J E, Young P et al.. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J. 2002; 20 306-312
52 Lumb A B. Nunn's Applied Respiratory Physiology. 6th ed. Philadelphia; Elsevier Butterworth Heinemann 2005
53 Eves N D, Petersen S R, Haykowsky M J, Wong E Y, Jones R L. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 174 763-771
54 Palange P, Valli G, Onorati P et al.. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol. 2004; 97 1637-1642
55 Marciniuk D D, Butcher S J, Reid J K et al.. The effects of helium-hyperoxia on 6-min walking distance in COPD: a randomized, controlled trial. Chest. 2007; 131 1659-1665
56 Johnson J E, Gavin D J, Adams-Dramiga S. Effects of training with heliox and noninvasive positive pressure ventilation on exercise ability in patients with severe COPD. Chest. 2002; 122 464-472
57 Eves N D, Sandmeyer L C, Wong E Y et al.. Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD. Chest. 2009; 135 609-618
58 Engelen M P, Schols A M, Baken W C, Wesseling G J, Wouters E F. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J. 1994; 7 1793-1797
59 Laaban J P, Kouchakji B, Dore M F, Orvoen-Frija E, David P, Rochemaure J. Nutritional status of patients with chronic obstructive pulmonary disease and acute respiratory failure. Chest. 1993; 103 1362-1368
60 Gosker H R, Lencer N H, Franssen F M, van der Vusse G J, Wouters E F, Schols A M. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest. 2003; 123 1416-1424
61 Schols A M, Soeters P B, Dingemans A M, Mostert R, Frantzen P J, Wouters E F. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993; 147 1151-1156
62 Wilson D O, Rogers R M, Wright E C, Anthonisen N R. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial . Body weight in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989; 139 1435-1438
63 Kobayashi A, Yoneda T, Yoshikawa M et al.. The relation of fat-free mass to maximum exercise performance in patients with chronic obstructive pulmonary disease. Lung. 2000; 178 119-127
64 Mostert R, Goris A, Weling-Scheepers C, Wouters E F, Schols A M. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med. 2000; 94 859-867
65 Nishimura Y, Tsutsumi M, Nakata H, Tsunenari T, Maeda H, Yokoyama M. Relationship between respiratory muscle strength and lean body mass in men with COPD. Chest. 1995; 107 1232-1236
66 Sahebjami H, Doers J T, Render M L, Bond T L. Anthropometric and pulmonary function test profiles of outpatients with stable chronic obstructive pulmonary disease. Am J Med. 1993; 94 469-474
67 Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med. 1999; 159(4 Pt 2) S1-S40
68 Allaire J, Maltais F, Doyon J F et al.. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax. 2004; 59 673-678
69 Couillard A, Maltais F, Saey D et al.. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003; 167 1664-1669
70 Gosker H R, van Mameren H, van Dijk P J et al.. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J. 2002; 19 617-625
71 Agustí A G, Sauleda J, Miralles C et al.. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002; 166 485-489
72 Koechlin C, Couillard A, Cristol J P et al.. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD?. Eur Respir J. 2004; 23 538-544
73 Koechlin C, Couillard A, Simar D et al.. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?. Am J Respir Crit Care Med. 2004; 169 1022-1027
74 Maltais F, LeBlanc P, Whittom F et al.. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax. 2000; 55 848-853
75 Whittom F, Jobin J, Simard P M et al.. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc. 1998; 30 1467-1474
76 Maltais F, Jobin J, Sullivan M J et al.. Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol. 1998; 84 1573-1580
77 Maltais F, Simard A A, Simard C, Jobin J, Desgagnés P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med. 1996; 153 288-293
78 Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996; 153 976-980
79 Saey D, Debigare R, LeBlanc P et al.. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003; 168 425-430
80 Killian K J, Leblanc P, Martin D H, Summers E, Jones N L, Campbell E J. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis. 1992; 146 935-940
81 Mador M J, Kufel T J, Pineda L A, Sharma G K. Diaphragmatic fatigue and high-intensity exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 161 118-123
82 Sala E, Roca J, Marrades R M et al.. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 159 1726-1734
83 Maltais F, LeBlanc P, Simard C et al.. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996; 154(2 Pt 1) 442-447
84 Schols A. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease. Proc Nutr Soc. 2003; 62 783-791
85 Schols A M, Soeters P B, Mostert R, Saris W H, Wouters E F. Energy balance in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1991; 143 1248-1252
86 Ferreira I M, Brooks D, Lacasse Y, Goldstein R S, White J. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005; (2) CD000998
87 Steiner M C, Barton R L, Singh S J, Morgan M D. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax. 2003; 58 745-751
88 Broekhuizen R, Creutzberg E C, Weling-Scheepers C A, Wouters E F, Schols A M. Optimizing oral nutritional drink supplementation in patients with chronic obstructive pulmonary disease. Br J Nutr. 2005; 93 965-971
89 Bhasin S, Woodhouse L, Casaburi R et al.. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001; 281 E1172-E1181
90 Bhasin S, Storer T W, Berman N et al.. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996; 335 1-7
91 Harman S M, Metter E J, Tobin J D, Pearson J, Blackman M R. Baltimore Longitudinal Study of Aging . Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001; 86 724-731
92 Amory J K, Watts N B, Easley K A et al.. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab. 2004; 89 503-510
93 Kenny A M, Prestwood K M, Gruman C A, Marcello K M, Raisz L G. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci. 2001; 56 M266-M272
94 Snyder P J, Peachey H, Hannoush P et al.. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab. 1999; 84 2647-2653
95 Kamischke A, Kemper D E, Castel M A et al.. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J. 1998; 11 41-45
96 Forbes G B, Halloran E. The adult decline in lean body mass. Hum Biol. 1976; 48 161-173
97 Murray M P, Gardner G M, Mollinger L A, Sepic S B. Strength of isometric and isokinetic contractions: knee muscles of men aged 20 to 86. Phys Ther. 1980; 60 412-419
98 Riggs B L, Wahner H W, Seeman E et al.. Changes in bone mineral density of the proximal femur and spine with aging: differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest. 1982; 70 716-723
99 Cabasso A. Peliosis hepatis in a young adult bodybuilder. Med Sci Sports Exerc. 1994; 26 2-4
100 Snyder P J. Androgens. In: Brunton LL, Lazo JS, Parker KL Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 11th ed. New York, NY; McGraw-Hill 2006: 1573-1586
101 Drinka P J, Jochen A L, Cuisinier M, Bloom R, Rudman I, Rudman D. Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels. J Am Geriatr Soc. 1995; 43 899-901
102 Casaburi R, Bhasin S, Cosentino L et al.. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004; 170 870-878
103 Creutzberg E C, Wouters E F, Mostert R, Pluymers R J, Schols A M. A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest. 2003; 124 1733-1742
104 Ferreira I M, Verreschi I T, Nery L E et al.. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest. 1998; 114 19-28
105 Schols A M, Soeters P B, Mostert R, Pluymers R J, Wouters E F. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: a placebo-controlled randomized trial. Am J Respir Crit Care Med. 1995; 152(4 Pt 1) 1268-1274
106 Greenhaff P L. Creatine and its application as an ergogenic aid. Int J Sport Nutr. 1995; 5(Suppl) S100-S110
107 Harris R C, Söderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Lond). 1992; 83 367-374
108 Nissen S L, Sharp R L. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol. 2003; 94 651-659
109 Brose A, Parise G, Tarnopolsky M A. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. J Gerontol A Biol Sci Med Sci. 2003; 58 11-19
110 Chrusch M J, Chilibeck P D, Chad K E, Davison K S, Burke D G. Creatine supplementation combined with resistance training in older men. Med Sci Sports Exerc. 2001; 33 2111-2117
111 Branch J D. Effect of creatine supplementation on body composition and performance: a meta-analysis. Int J Sport Nutr Exerc Metab. 2003; 13 198-226
112 Andrews R, Greenhaff P, Curtis S, Perry A, Cowley A J. The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure. Eur Heart J. 1998; 19 617-622
113 Jacobs P L, Mahoney E T, Cohn K A, Sheradsky L F, Green B A. Oral creatine supplementation enhances upper extremity work capacity in persons with cervical-level spinal cord injury. Arch Phys Med Rehabil. 2002; 83 19-23
114 Tarnopolsky M A, Roy B D, MacDonald J R. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve. 1997; 20 1502-1509
115 Vorgerd M, Grehl T, Jager M et al.. Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol. 2000; 57 956-963
116 Fiaccadori E, Del Canale S, Vitali P, Coffrini E, Ronda N, Guariglia A. Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia. Chest. 1987; 92 883-887
117 Fuld J P, Kilduff L P, Neder J A et al.. Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax. 2005; 60 531-537
118 Faager G, Söderlund K, Sköld C M, Rundgren S, Tollbäck A, Jakobsson P. Creatine supplementation and physical training in patients with COPD: a double blind, placebo-controlled study. Int J Chron Obstruct Pulmon Dis. 2006; 1 445-453
119 Deacon S J, Vincent E E, Greenhaff P L et al.. Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 178 233-239
120 Rodríguez-Arnao J, Jabbar A, Fulcher K, Besser G M, Ross R J. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults. Clin Endocrinol (Oxf). 1999; 51 53-60
121 Salomon F, Cuneo R C, Hesp R, Sönksen P H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989; 321 1797-1803
122 Pape G S, Friedman M, Underwood L E, Clemmons D R. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest. 1991; 99 1495-1500
123 Burdet L, de Muralt B, Schutz Y, Pichard C, Fitting J W. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease: a prospective, randomized, controlled study. Am J Respir Crit Care Med. 1997; 156 1800-1806
124 Shahar E, Folsom A R, Melnick S L Atherosclerosis Risk in Communities Study Investigators et al. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N Engl J Med. 1994; 331 228-233
125 Agustí A, Morlá M, Sauleda J, Saus C, Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax. 2004; 59 483-487
126 Moses A W, Slater C, Preston T, Barber M D, Fearon K C. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 2004; 90 996-1002
127 Aguilaniu B, Flore P, Perrault H, Page J E, Payan E, Lacour J R. Exercise-induced hypoxaemia in master athletes: effects of a polyunsaturated fatty acid diet. Eur J Appl Physiol Occup Physiol. 1995; 72 44-50
128 Broekhuizen R, Wouters E F, Creutzberg E C, Weling-Scheepers C A, Schols A M. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax. 2005; 60 376-382

Roger GoldsteinM.D.

West Park Healthcare Centre

82 Buttonwood Ave., Toronto, ON, M6M 2J5 Canada

Email: rgoldstein@westpark.org